Study of AGEN1884 With Pembrolizumab in 1L NSCLC
Clinical trial NCT03411473 · TERMINATED
Trial details
- NCT number
- NCT03411473
- Sponsor
- Agenus Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-04
- Primary completion
- 2018-05-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.